Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atara Biotherapeutics (ATRA) Amortizatization of Intangibles (2022 - 2026)

Atara Biotherapeutics filings provide 5 years of Amortizatization of Intangibles readings, the most recent being $814000.0 for Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles rose 414.29% to $814000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $814000.0, a 70.97% decrease, with the full-year FY2025 number at -$259000.0, down 106.3% from a year prior.
  • Amortizatization of Intangibles hit $814000.0 in Q1 2026 for Atara Biotherapeutics, up from -$84000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $4.1 million in Q4 2024 to a low of -$2.0 million in Q3 2025.
  • Median Amortizatization of Intangibles over the past 5 years was $57000.0 (2024), compared with a mean of $496000.0.
  • Biggest five-year swings in Amortizatization of Intangibles: soared 2226.0% in 2023 and later tumbled 3580.7% in 2025.
  • Atara Biotherapeutics' Amortizatization of Intangibles stood at -$50000.0 in 2022, then soared by 2226.0% to $1.1 million in 2023, then surged by 283.73% to $4.1 million in 2024, then plummeted by 102.06% to -$84000.0 in 2025, then surged by 1069.05% to $814000.0 in 2026.
  • The last three reported values for Amortizatization of Intangibles were $814000.0 (Q1 2026), -$84000.0 (Q4 2025), and -$2.0 million (Q3 2025) per Business Quant data.